These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 19739256

  • 1. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X, Wu K, Fan D.
    Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
    [No Abstract] [Full Text] [Related]

  • 2. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X, Wu K, Fan D.
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract] [Full Text] [Related]

  • 3. Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
    Riener MO, Stenner F, Liewen H, Hellerbrand C, Bahra M, Kristiansen G.
    Hepatology; 2009 Jul; 50(1):326. PubMed ID: 19496179
    [No Abstract] [Full Text] [Related]

  • 4. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL, Yang HY, Xu HF, Sang XT, Lu X, Yang ZY, Zhang JC, Zhong SX, Huang JF, Zhang HB.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):948-51. PubMed ID: 18756964
    [Abstract] [Full Text] [Related]

  • 5. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
    Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM.
    J Hepatol; 2005 Dec 08; 43(6):1007-12. PubMed ID: 16137783
    [Abstract] [Full Text] [Related]

  • 6. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
    Mao Y, Yang H, Xu H, Lu X, Sang X, Du S, Zhao H, Chen W, Xu Y, Chi T, Yang Z, Cai J, Li H, Chen J, Zhong S, Mohanti SR, Lopez-Soler R, Millis JM, Huang J, Zhang H.
    Gut; 2010 Dec 08; 59(12):1687-93. PubMed ID: 20876776
    [Abstract] [Full Text] [Related]

  • 7. [Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expresssion in primary hepatic carcinoma].
    Xu WF, Fei YM, Zhou JK, Shen HJ, Chen XF, Lv QQ, Ding YY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug 08; 25(4):286-8. PubMed ID: 22097609
    [Abstract] [Full Text] [Related]

  • 8. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 08; 12(8):492. PubMed ID: 15329213
    [No Abstract] [Full Text] [Related]

  • 9. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
    Gonzalez SA, Jacobson IM.
    Am J Gastroenterol; 2005 Apr 08; 100(4):977-8. PubMed ID: 15784045
    [No Abstract] [Full Text] [Related]

  • 10. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
    Ottó S.
    Orv Hetil; 2004 Feb 15; 145(7 Suppl 1):385-7. PubMed ID: 15049057
    [Abstract] [Full Text] [Related]

  • 11. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.
    Kar P, Gandhi BM, Irshad M, Gupta H, Tandon BN.
    J Assoc Physicians India; 1987 Apr 15; 35(4):288-9. PubMed ID: 2443479
    [No Abstract] [Full Text] [Related]

  • 12. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
    Teofănescu I, Gologan E, Stefănescu G, Bălan G.
    Rev Med Chir Soc Med Nat Iasi; 2010 Apr 15; 114(1):39-46. PubMed ID: 20509274
    [Abstract] [Full Text] [Related]

  • 13. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.
    Ann Surg Oncol; 2009 Oct 15; 16(10):2795-804. PubMed ID: 19669841
    [Abstract] [Full Text] [Related]

  • 14. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I, Beaudonnet A, Pichot J, Roubille M, Gelineau M.
    Ann Biol Clin (Paris); 2000 Oct 15; 58(1):85-90. PubMed ID: 10673618
    [No Abstract] [Full Text] [Related]

  • 15. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
    Forner A, Reig M, Bruix J.
    Gastroenterology; 2009 Jul 15; 137(1):26-9. PubMed ID: 19482098
    [No Abstract] [Full Text] [Related]

  • 16. [Biological markers of hepatocellular carcinoma].
    Arfaoui D, Elloumi H, Ajmi S.
    Tunis Med; 2004 Apr 15; 82(4):329-34. PubMed ID: 15453027
    [Abstract] [Full Text] [Related]

  • 17. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A, Fraquelli M, Conte D.
    Am J Gastroenterol; 2006 Aug 15; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract] [Full Text] [Related]

  • 18. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK, Khandekar JD.
    Arch Intern Med; 2007 Sep 24; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract] [Full Text] [Related]

  • 19. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB, Attar BM, Shimoda SS.
    Am J Gastroenterol; 1995 Jun 24; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract] [Full Text] [Related]

  • 20. Glypican-3 as a serum marker for hepatocellular carcinoma.
    Capurro M, Filmus J.
    Cancer Res; 2005 Jan 01; 65(1):372; author reply 372-3. PubMed ID: 15665316
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.